论文信息 - Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity - 字舞流文

Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity

W. Berdel | N. Thoennissen | R. Mesters | C. Schliemann | R. Mesters | R. Bieker | M. Zühlsdorf | L. Zahiragic | K. Burow | C. Kramer | Wolfgang E. Berdel | Nils H. Thoennissen | Michael Zühlsdorf